ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9765
0.19%
Brent Oil
83.63
0.11%
Bitcoin
59,315.34
1.85%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. ANI Pharmaceuticals Inc (ANIP)

  7. ANI Pharmaceuticals Inc (ANIP) Noticias

ANIP

ANI Pharmaceuticals (ANIP)

ANI Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ANIP
FechaHoraFuenteTítuloSímboloCompañía
01/05/202415:30GlobeNewswire Inc.ANI Pharmaceuticals to Participate at Two Upcoming Healthcare ConferencesNASDAQ:ANIPANI Pharmaceuticals Inc
18/04/202415:05GlobeNewswire Inc.ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ETNASDAQ:ANIPANI Pharmaceuticals Inc
09/04/202405:50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Baclofen Oral SuspensionNASDAQ:ANIPANI Pharmaceuticals Inc
04/04/202405:50GlobeNewswire Inc.ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with SarcoidosisNASDAQ:ANIPANI Pharmaceuticals Inc
03/04/202405:50GlobeNewswire Inc.ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma SymposiumNASDAQ:ANIPANI Pharmaceuticals Inc
27/03/202405:50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Levofloxacin Oral Solution, USPNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202418:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
08/03/202416:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
29/02/202406:22Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIPANI Pharmaceuticals Inc
29/02/202405:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIPANI Pharmaceuticals Inc
29/02/202405:50GlobeNewswire Inc.ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 GuidanceNASDAQ:ANIPANI Pharmaceuticals Inc
20/02/202405:50GlobeNewswire Inc.ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ANIPANI Pharmaceuticals Inc
07/02/202405:50GlobeNewswire Inc.ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024, at 8:30 a.m. ETNASDAQ:ANIPANI Pharmaceuticals Inc
29/01/202405:50GlobeNewswire Inc.ANI Pharmaceuticals to Participate at the Guggenheim Healthcare Talks | 6th Annual Biotechnology ConferenceNASDAQ:ANIPANI Pharmaceuticals Inc
23/01/202415:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIPANI Pharmaceuticals Inc
23/01/202405:50GlobeNewswire Inc.ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USPNASDAQ:ANIPANI Pharmaceuticals Inc
17/01/202406:45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIPANI Pharmaceuticals Inc
16/01/202405:50GlobeNewswire Inc.ANI Pharmaceuticals Announces the FDA Approval and Launch of Indomethacin Oral Suspension, USPNASDAQ:ANIPANI Pharmaceuticals Inc
22/11/202308:26GlobeNewswire Inc.ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ANIPANI Pharmaceuticals Inc
20/11/202319:58Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:ANIPANI Pharmaceuticals Inc
08/11/202306:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIPANI Pharmaceuticals Inc
08/11/202305:50GlobeNewswire Inc.ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 GuidanceNASDAQ:ANIPANI Pharmaceuticals Inc
25/10/202305:50GlobeNewswire Inc.ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ETNASDAQ:ANIPANI Pharmaceuticals Inc
02/10/202305:50GlobeNewswire Inc.ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis FlaresNASDAQ:ANIPANI Pharmaceuticals Inc
18/09/202315:05GlobeNewswire Inc.ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023NASDAQ:ANIPANI Pharmaceuticals Inc
12/09/202305:50GlobeNewswire Inc.ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USPNASDAQ:ANIPANI Pharmaceuticals Inc
28/08/202305:50GlobeNewswire Inc.ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%NASDAQ:ANIPANI Pharmaceuticals Inc
24/08/202305:50GlobeNewswire Inc.ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ANIPANI Pharmaceuticals Inc
23/08/202319:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ANIPANI Pharmaceuticals Inc
23/08/202305:50GlobeNewswire Inc.ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of DirectorsNASDAQ:ANIPANI Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ANIP

Su Consulta Reciente

NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
NASDAQ
AAPL
Apple
FX
EURMXN
Euro vs MXN
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
NYSE
BAC
Bank of America
NYSE
MCD
McDonalds
NYSE
VZ
Verizon Communications
FX
EURUSD
Euro vs US Dollar
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados